Quick Answer
REGENXBIO Inc. reported Stockholders Equity of $102.73 million for fiscal year 2025.
REGENXBIO Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $102.73M | -60.4% |
| 2024 | $259.65M | -16.7% |
| 2023 | $311.74M | -39.6% |
| 2022 | $516.20M | -32.5% |
| 2021 | $764.30M | +102.3% |
| 2020 | $377.75M | -16.1% |
| 2019 | $450.20M | -11.5% |
| 2018 | $508.85M | +178.0% |
| 2017 | $183.03M | +13.2% |
| 2016 | $161.74M | -25.4% |
| 2015 | $216.81M | +1285.3% |
| 2014 | -$18.29M | -31.4% |
| 2013 | -$13.92M | -71.6% |
| 2012 | -$8.11M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $161.45M | -46.4% | -24.4% |
| June 30, 2025 | $213.68M | -38.6% | -22.1% |
| March 31, 2025 | $274.20M | -29.8% | +5.6% |
| December 31, 2024 | $259.65M | -16.7% | -13.9% |
| September 30, 2024 | $301.42M | -17.0% | -13.5% |
| June 30, 2024 | $348.27M | -14.2% | -10.9% |
| March 31, 2024 | $390.67M | -16.0% | +25.3% |
| December 31, 2023 | $311.74M | -39.6% | -14.1% |
- REGENXBIO Inc. showed a decrease of -60.4% in Stockholders Equity compared to the prior fiscal year.
- Over the 2012–2025 period, REGENXBIO Inc.’s stockholders equity has grown by 1366.4% (from -$8.11 million to $102.73 million).
- The most recent figure is from REGENXBIO Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 5, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: